Wireless sensor could help doctors Fine-Tune heart failure treatment in real time

NCT ID NCT06241430

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study tests whether a small wireless sensor placed in the pulmonary artery can help doctors better manage medications for people with heart failure and a leaky mitral valve. The sensor constantly measures pressure inside the heart, giving doctors real-time data to adjust treatments. Participants already scheduled for a non-surgical valve repair will also receive the sensor. The goal is to see if this leads to better symptom control and quality of life over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
CardioMEMS wireless pulmonary artery pressure sensor
What this could lead to
If successful, this approach could help doctors fine-tune heart failure medications in real time, potentially reducing hospitalizations and improving quality of life.
What could go wrong
This is a small, early-stage study (60 people) focused on feasibility and outcomes like symptom scores, not survival. The sensor requires a procedure and may not benefit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Columbia University Irving Medical Center / NewYork-Presbyterian Hospital

    RECRUITING

    New York, New York, 10032, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.